Spain’s Grifols to test plasma therapy for COVID-19 with U.S. FDA

Spain’s Grifols has agreed to work with the U.S. Food and Drug Administration and other agencies to gather plasma from patients who have recovered from COVID-19 and test potential therapies for the disease, the pharmaceutical firm said on Wednesday.
The plasma will be processed to produce hyperimmune immunoglobins, which will then be put to pre-clinical and clinical tests to see if they can help treat the disease, Grifols said in a statement.
https://www.reuters.com/article/us-health-coronavirus-grifols/spains-grifols-to-test-plasma-therapy-for-covid-19-with-u-s-fda-idUSKBN21C3IA